GLENMEDE TRUST CO NA - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$0
-100.0%
11
-99.1%
0.00%
Q1 2020$1,0000.0%1,1850.0%0.00%
Q4 2019$1,000
-50.0%
1,1850.0%0.00%
Q3 2019$2,000
-99.8%
1,185
-99.2%
0.00%
-100.0%
Q2 2019$1,100,000
-42.1%
143,549
+0.3%
0.01%
-44.4%
Q1 2019$1,901,000
-14.6%
143,129
+0.1%
0.01%
-18.2%
Q4 2018$2,225,000
-20.7%
142,917
+0.0%
0.01%0.0%
Q3 2018$2,807,000
-31.5%
142,8720.0%0.01%
-38.9%
Q2 2018$4,100,000
+34.3%
142,872
+0.4%
0.02%
+38.5%
Q1 2018$3,052,0000.0%142,3360.0%0.01%0.0%
Q4 2017$3,052,000
-9.4%
142,336
-0.1%
0.01%
-13.3%
Q3 2017$3,367,000
+161.0%
142,440
+131.6%
0.02%
+150.0%
Q2 2017$1,290,0000.0%61,5000.0%0.01%0.0%
Q1 2017$1,290,000
+12.0%
61,500
+0.2%
0.01%0.0%
Q4 2016$1,152,000
-24.0%
61,347
-15.6%
0.01%
-33.3%
Q3 2016$1,516,000
-27.7%
72,707
-11.7%
0.01%
-30.8%
Q2 2016$2,098,000
+62.0%
82,321
+68.1%
0.01%
+62.5%
Q1 2016$1,295,000
-38.0%
48,982
+0.2%
0.01%
-42.9%
Q4 2015$2,090,000
+28.8%
48,890
-20.2%
0.01%
+16.7%
Q3 2015$1,623,000
+43.9%
61,250
+80.7%
0.01%
+50.0%
Q2 2015$1,128,000
+0.4%
33,896
+0.3%
0.01%0.0%
Q1 2015$1,124,000
-18.6%
33,7800.0%0.01%
-27.3%
Q4 2014$1,380,000
+20.6%
33,7800.0%0.01%
+10.0%
Q3 2014$1,144,00033,7800.01%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 815,838$27,192,0003.30%
ARMISTICE CAPITAL, LLC 186,000$6,199,0002.23%
1492 Capital Management LLC 95,639$3,188,0002.02%
Partner Investment Management, L.P. 19,498$650,0000.91%
Tekla Capital Management LLC 680,862$22,693,0000.82%
PFM Health Sciences, LP 817,396$27,244,0000.69%
HighPoint Advisor Group LLC 11,829$394,0000.61%
ARBOR CAPITAL MANAGEMENT LLC 89,183$2,972,0000.56%
Pergamon Offshore Advisors, L.P. 15,950$532,0000.56%
Penn Capital Management Company, LLC 390,212$13,006,0000.54%
View complete list of ACORDA THERAPEUTICS INC shareholders